Trillium Therapeutics (TRIL) Stock: Gaining On Clinical Update

Trillium Therapeutics Inc (NASDAQ: TRIL) is having an incredibly strong start to the trading session this morning, and for good reason. The company said that it would be providing updates on two clinical trials at two upcoming scientific conferences. Of course, the news excited investors who are sending the stock on a run for the … Read more